Edition:
United Kingdom

Aridis Pharmaceuticals Inc (ARDS.OQ)

ARDS.OQ on NASDAQ Stock Exchange Capital Market

10.32USD
18 Apr 2019
Change (% chg)

-- (--)
Prev Close
$10.32
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,927
52-wk High
$13.85
52-wk Low
$7.59

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 1.39 -0.670
Sep '18 1.02 -0.976
Jun '18 0.02 -0.242
Mar '18 0.32 -1.033
FY 2017 Dec '17 0.79 -0.724
Sep '17 0.02 -0.786
Jun '17 0.02 -0.860
Mar '17 0.02 -1.108
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 2 0.73 0.75 0.70 --
Quarter Ending Sep-19 3 0.98 1.50 0.70 --
Year Ending Dec-19 4 2.25 3.00 0.00 --
Year Ending Dec-20 4 2.25 3.00 0.00 --
Earnings (per share)
Quarter Ending Jun-19 3 -0.72 -0.60 -0.80 --
Quarter Ending Sep-19 3 -0.56 -0.51 -0.59 --
Year Ending Dec-19 4 -2.71 -2.50 -2.95 --
Year Ending Dec-20 4 -2.79 -2.12 -4.05 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.30 32.55
P/E High - Last 5 Yrs. -- 147.69 48.10
P/E Low - Last 5 Yrs. -- 47.94 23.42
Beta -- 1.08 0.87
Price to Sales (TTM) -- 49.51 8.39
Price to Book (MRQ) -- 10.13 5.27
Price to Tangible Book (MRQ) -- 13.74 6.74
Price to Cash Flow (TTM) -- 56.17 24.13
% Owned Institutions -- 3.71 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.02 39.61

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.06 13.46
Sales (TTM) vs TTM 1 Yr. Ago -- 49.01 8.04
Sales - 5 Yr. Growth Rate -- 22.77 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.31 47.73
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate -- 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) -- 3.57 2.98
LT Debt to Equity (MRQ) -- 18.63 11.32
Total Debt to Equity (MRQ) -- 31.30 16.01
Interest Coverage (TTM) -- -43.11 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.28 52.41
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.67 12.41
Operating Margin (TTM) -- -184.95 5.77
Operating Margin - 5 Yr. Avg. -- -127.15 8.01
Pre-Tax Margin (TTM) -- -175.66 4.79
Pre-Tax Margin - 5 Yr. Avg. -- -132.95 8.29
Net Profit Margin (TTM) -- -182.38 1.52
Net Profit Margin - 5 Yr. Avg. -- -137.34 4.70
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,653,551 820,412,980
Net Income/Employee (TTM) -- 513,615 92,866,230
Receivable Turnover (TTM) -- 6.28 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) -- 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.38 10.60
Return on Assets - 5 Yr. Avg. -- 5.47 11.78
Return on Investment (TTM) -- 8.91 13.83
Return on Investment - 5 Yr. Avg. -- 6.79 15.32
Return on Equity (TTM) -- 10.06 15.25
Return on Equity - 5 Yr. Avg. -- 8.32 16.41

Performance for Aridis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.76%
# of Holders: 6
Total Shares Held: 61,361
3 Mo. Net Change: 41,438
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.